Spectral AI
Spectral AI develops artificial intelligence-driven diagnostic solutions for wound management, with a focus on burns and diabetic foot ulcers. Utilizing multispectral imaging and advanced machine learning algorithms, the company provides objective, real-time predictions of wound healing potential to support clinical decision-making. Their technology improves accuracy in wound assessment, helping clinicians address diagnostic gaps and reducing subjectivity in care. Spectral AI’s solutions support both risk stratification and treatment planning, aiming to optimize outcomes and reduce healing-related complications.
Industries
N/A
Spectral AI
2515 McKinney Ave, Suite #1000, Dallas, TX, 75201, United States
Products
A platform leveraging multispectral imaging and AI algorithms to objectively assess and predict wound healing potential, supporting clinical decision-making for burns and diabetic foot ulcers.
A platform leveraging multispectral imaging and AI algorithms to objectively assess and predict wound healing potential, supporting clinical decision-making for burns and diabetic foot ulcers.
Expertise Areas
- Medical imaging in wound care
- Artificial intelligence in diagnostics
- Burn and diabetic wound prediction
- Machine learning model development
Key Technologies
- Multispectral imaging
- Machine learning
- Deep learning
- Predictive analytics
Key People
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Chief Operating Officer
Head of Global Regulatory Affairs
General Manager – Manufacturing
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Chief Operating Officer
Head of Global Regulatory Affairs
General Manager – Manufacturing
News & Updates
Received FDA De Novo clearance for the DeepView system in burn wound management.
Recognized as the Best Technology winner at the European Mediscience Awards 2022.
Featured among TIME's Top HealthTech Companies in 2025.
Recipient of the Small Business Innovator Award at the Texas Innovation Conference.
Report on the superior performance of Spectral AI's algorithms compared with physicians in burn tissue assessment, with plans for FDA submission.
Report on the clinical use of AI imaging tools for burn assessment in a UK burn center.
Received FDA De Novo clearance for the DeepView system in burn wound management.
Recognized as the Best Technology winner at the European Mediscience Awards 2022.
Featured among TIME's Top HealthTech Companies in 2025.
Recipient of the Small Business Innovator Award at the Texas Innovation Conference.
Report on the superior performance of Spectral AI's algorithms compared with physicians in burn tissue assessment, with plans for FDA submission.
Report on the clinical use of AI imaging tools for burn assessment in a UK burn center.